An anonymous director reports

ONCOLYTICS BIOTECH TO HOST CONFERENCE CALL TO DISCUSS SECOND QUARTER FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS

Oncolytics Biotech Inc. will host a conference call and webcast on Monday, Aug. 14, 2023, at 8:30 a.m. ET to discuss a corporate update and financial results for the second quarter of 2023.

Conference call details

Date:  Monday, Aug. 14, 2023

Time:  8:30 a.m. ET

North American toll-free dial-in:  888-664-6383

International dial-in:  416-764-8650

Conference ID (if needed):  5411-4798

A webcast of the call will also be available on the investor relations page of the company's website and will be archived for three months. A dial-in replay will be available for one week and can be accessed by dialling 888-390-0541 (North America) or 416-764-8677 (international) and using replay code 114-798 followed by the pound key.

About Oncolytics Biotech Inc.

Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. This compound induces anti-cancer immune responses and promotes an inflamed tumour phenotype -- turning "cold" tumours "hot" -- through innate and adaptive immune responses to treat a variety of cancers.